Literature DB >> 31492371

Evaluation of Different Blood Circulating miRNAs for Hepatocellular Carcinoma Diagnosis.

Shutong Wang1, Jian Wu1, Shunli Shen1, Zhijun Geng2, Yunzhi Ling3, Baogang Peng1.   

Abstract

The current study was conducted to investigate the potential of three circulating miRNAs (miR-21, miR-16 and miR-100) as HCC diagnostic marker in the population living in Guangdong province, China. First, the Fe₃O₄ and Fe₃O₄@SiO₂ magnetic microsphere were prepared. Fe₃O₄@SiO₂ microspheres were further used for total RNA purification from serum. After that, the real-time qPCR was conducted for the detecting the miRNA in the serum of HCC patients and healthy volunteers. Scanning electron microscope and transmission electron microscope images showed that monodisperse Fe₃O₄ and Fe₃O₄@SiO₂ microspheres were successfully synthesized with a mean diameter of about 500 nm and 600 nm, respectively. The microsphere was spherical in shape with good state of dispersion. The characteristic peak at 1088.8 cm-1 in FTIR spectra belonged to the asymmetry stretching vibration of Si-O-Si, which confirmed the SiO₂ coating on Fe₃O₄ microspheres. The successful amplification of miRNAs in qPCR verified that the total RNA extracted using the Fe₃O₄@SiO₂ microspheres retained high quality. The real time PCR results showed that miR-21 was differentially expressed in the serum of HCC patients and healthy volunteers. miR-21 and alpha-fetoprotein (AFP) together could be potentially used as HCC diagnostic marker in Guangdong province population in China.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31492371     DOI: 10.1166/jnn.2020.17160

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  2 in total

Review 1.  Extracellular Vesicles and Hepatocellular Carcinoma: Opportunities and Challenges.

Authors:  Juan Wang; Xiaoya Wang; Xintong Zhang; Tingting Shao; Yanmei Luo; Wei Wang; Yunwei Han
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

2.  Prognostic role of urokinase plasminogen activator in hepatocellular carcinoma: A protocol for systematic review and meta analysis.

Authors:  Pengxian Tao; Lei Gao; Haiyuan Li; Bofang Wang; Xuemei Li; Ying Zhang; Hao Chen
Journal:  Medicine (Baltimore)       Date:  2020-12-24       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.